21 October 2022 | Other

Pfizer to quadruple COVID vaccine cost

Pfizer Inc. expects to roughly quadruple the price of its COVID-19 vaccine, according to Pfizer CEO Angela Lukin. The price of the vaccine will probably vary from $110-$130 per dose after the current US government procurement program expires.

Earlier, Reuters reported that Wall Street expected such a price increase due to weak demand for COVID vaccines. Consequently, vaccine manufacturers will need to raise prices to meet revenue projections for 2023.

Presumably in 2023, the market will shift to private insurance after the U.S. public health emergency expires. At the moment, the US government pays Pfizer about $30 per dose.

According to Angela Lukin, the price of vaccines in the US reflects its overall cost-effectiveness. The Pfizer CEO also ensures that the price of the vaccine is going to be affordable for patients.

It is not yet clear whether people without health insurance will get access to the vaccine. Lukin said that vaccine procurement turning over to the private sector before the first quarter of 2023 is unlikely. Completion of this step depends on the depletion of government supply contracts.



Company MarketCheese
Period: 11.07.2025 Expectation: 920 pips
GBPUSD falls as UK GDP unexpectedly shrinks
Today at 10:42 AM 3
Brent sell
Period: 17.07.2025 Expectation: 150 pips
OPEC's gloomy forecast drags Brent crude prices lower
Today at 08:53 AM 9
Period: 17.07.2025 Expectation: 26000 pips
Institutional investor demand could push ETHUSD to 3,000
Yesterday at 10:38 AM 35
Period: 16.07.2025 Expectation: 2000 pips
USDJPY prepares to retest 148 Level
Yesterday at 08:19 AM 38
Period: 16.07.2025 Expectation: 900 pips
NVIDIA shares rise amid global AI infrastructure investments
09 July 2025 66
Period: 15.07.2025 Expectation: 800 pips
Breaking downtrend could push USDCAD to 1.375
09 July 2025 44
Go to forecasts